BetterLife Pharma BETRF
OTC BETRF
$0.26 +0.03 (+13.04%)
At close: Aug 19, 2026 · 4:00 PM EDT

BetterLife Pharma (BETRF) Debt Ratio (2011 - 2026)

BetterLife Pharma (BETRF) posted quarterly Debt Ratio of 6.81 for Q2 2026, up 81.79% year-over-year from 3.75 in Q2 2025, and up 0.61% quarter-over-quarter from 6.77 in Q1 2026.

BetterLife Pharma (BETRF) Debt Ratio (2011 - 2026) Analysis & Trends

BetterLife Pharma's Debt Ratio history runs 16 years deep, the most recent figure standing at 6.81 for Q2 2026.

  • In Q2 2026, Debt Ratio rose 81.79% year-over-year to 6.81; the TTM figure through Apr 2026 stood at 6.81 (up 81.79% YoY), while the FY2026 annual figure was 6.77, up 2944.14% from the prior year.
  • Debt Ratio for Q2 2026 stood at 6.81, up from 6.77 in the prior quarter.
  • The five-year high for Debt Ratio was 100.54 in Q1 2023, with the low at 0.22 in Q1 2025.
  • The 5-year median for Debt Ratio is 2.16 (2024), against an average of 9.76.
  • The sharpest annual moves came in 2023 and 2025: Debt Ratio surged 11467.38% in 2023, then slumped 99.05% in 2025.
  • BetterLife Pharma's Debt Ratio stood at 2.78 in 2022, then fell by 26.6% to 2.04 in 2023, then soared by 119.2% to 4.47 in 2024, then dropped by 2.74% to 4.35 in 2025, then surged by 56.7% to 6.81 in 2026.
  • Business Quant data shows BETRF's Debt Ratio at 6.81 in Q2 2026, 6.77 in Q1 2026, and 4.35 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 BetterLife Pharma 36.45 Mn 36.42 Mn - 0.65

Historic Data

Download Data
DateValue
Apr 30, 2026 6.81
Jan 31, 2026 6.77
Jul 31, 2025 4.35
Apr 30, 2025 3.75
Jan 31, 2025 0.22
Oct 31, 2024 4.47
Jul 31, 2024 2.16
Apr 30, 2024 1.63
Jan 31, 2024 23.44
Oct 31, 2023 2.04
Jul 31, 2023 2.07
Apr 30, 2023 0.97
Jan 31, 2023 100.54
Oct 31, 2022 2.78
Jul 31, 2022 1.99
Apr 30, 2022 1.02
Jan 31, 2022 0.87
Oct 31, 2021 0.07
Jul 31, 2021 0.07
Apr 30, 2021 0.46